Screening for Primary Sclerosing Cholangitis (PSC).
Detect Atypical pANCA and Atypical cANCA antibodies using the Indirect Immunofluorescence Technique (IFT).
Support diagnosis and monitor disease progression, especially in patients with bile duct disorders or inflammatory bowel disease.